 However, without waiting for the final results of these randomized trials which will not be fully valid with a drop of at least ten years, the American societies ASTRO and European ESTRO radiotherapy have all two proposed classification very similar into 3 groups according to the risk to the patient in terms of local recurrence after IPAS. And are defined by the ESTRO: 